The Australian Government has announced an expansion of respiratory syncytial virus (RSV) protection, with the inclusion of the RSV vaccine Arexvy on the National Immunisation Program (NIP) for eligible older adults. From 15 May 2026, a single free dose of Arexvy will be available for adults aged 75 and over and Aboriginal and Torres Strait Islander people aged 60 and over – aiming to reduce the burden of severe RSV illness and prevent hospitalisations among these at-risk groups. The initiative […]














